Cargando…
Design, synthesis and evaluation of a myricetin and nobiletin hybrid compound for alleviating hyperuricemia based on metabolomics and gut microbiota
Hyperuricemia (HUA) is the fourth most common basic metabolic disease that can cause damage to multiple organs throughout the body. In this study, a hybrid compound consisting of myricetin and nobiletin was synthesized and its biological activity was evaluated. We named the hybrid compound MNH, and...
Autores principales: | Li, Yan, Pu, Liu-Yang, Li, Yayun, Zhu, Guanbao, Wu, Zhengzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351364/ https://www.ncbi.nlm.nih.gov/pubmed/37465570 http://dx.doi.org/10.1039/d3ra03188h |
Ejemplares similares
-
A novel colchicine-myricetin heterozygous molecule: design, synthesis, and effective evaluations on the pathological models of acute lung injury in vitro and in vivo
por: Li, Zhiyue, et al.
Publicado: (2023) -
Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia
por: Liu, Ping, et al.
Publicado: (2023) -
Altered Gut Microbiota in Children With Hyperuricemia
por: Yuan, Xin, et al.
Publicado: (2022) -
The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia
por: Liu, Xiu, et al.
Publicado: (2020) -
Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia
por: Wang, Ruoyu, et al.
Publicado: (2022)